Lu Victor M, Pendleton Courtney, Brown Desmond A, Lakomkin Nikita, Cho Steve, Miller Kai J, Daniels David J
Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, United States.
Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, United States.
Clin Neurol Neurosurg. 2020 Jul;194:105895. doi: 10.1016/j.clineuro.2020.105895. Epub 2020 May 23.
The clinical management of medulloblastoma has undergone significant transformation since the recent dawn of the molecular era. The aim of this analysis was to evaluate citation and other bibliometric characteristics of the 100 most cited medulloblastoma articles in the literature to better understand the current state of our research efforts into this diagnosis. Elsevier's Scopus database was searched for the 100 most cited articles that focused on medulloblastoma. Articles were dichotomized as either primarily basic science (BSc) or clinical (CL) articles. Various bibliometric parameters were summarized and compared between BSc and CL articles using Pearson's Chi-square and Mann Whitney U tests. Of the 100 most cited articles, 52 were characterized as BSc articles and 48 as CL articles. Overall median (range) values were as follows: citation count 252 (164-1,270); citation rate per year 17.5 (2.5-110); number of authors 11 (1-135); and publication year 2005 (1925-2014). Articles were published in a total of 40 different journals, and the majority originated in the US (n = 60). When compared to CL articles, BSc articles reported significantly greater citation rates per year (P < 0.01), and more recent years of publication (P < 0.01). In summary, although similar in overall proportion, BSc articles demonstrated significantly increased bibliometric parameters of impact in this field by the successful clustering molecular subtypes. Moving forward, it will be of great interest to see how the findings from these impactful BSc articles will translate into future clinical initiatives and subsequently high-impact CL articles.
自分子时代初现以来，髓母细胞瘤的临床管理已发生显著变革。本分析旨在评估文献中被引用次数最多的100篇髓母细胞瘤文章的引用情况及其他文献计量学特征，以便更好地了解我们针对这一诊断的研究工作现状。在爱思唯尔的Scopus数据库中搜索了100篇被引用次数最多且聚焦于髓母细胞瘤的文章。文章被分为基础科学（BSc）类或临床（CL）类。使用Pearson卡方检验和Mann Whitney U检验对BSc类和CL类文章的各种文献计量学参数进行了总结和比较。在100篇被引用次数最多的文章中，52篇为BSc类文章，48篇为CL类文章。总体中位数（范围）值如下：引用次数252（164 - 1270）；每年引用率17.5（2.5 - 110）；作者数量11（1 - 135）；发表年份2005（1925 - 2014）。文章共发表于40种不同期刊，且大多数源自美国（n = 60）。与CL类文章相比，BSc类文章每年的引用率显著更高（P < 0.01），发表年份更近（P < 0.01）。总之，尽管总体比例相似，但BSc类文章通过成功聚类分子亚型，在该领域展示出显著更高的文献计量学影响力参数。展望未来，观察这些有影响力的BSc类文章的研究结果如何转化为未来的临床举措以及随后产生高影响力的CL类文章，将非常有趣。
